Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FONDACAST
2008-004181-10Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in venous thromboembolism (VTE) comparing Fondaparinux with Nadroparin active control (2 arms). Started Sep 2008; status: completed.
02
Drugs
fondaparinuxnadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2008-004181-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004181-10.